Research programme: transdermal therapeutics - Biotts
Latest Information Update: 10 Oct 2022
At a glance
- Originator Biotts
- Class Antihyperglycaemics; Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Diabetes mellitus
- Research Cancer